FDA Approval Of Hepatitis C Drugs For Kids Is Likely To Speed Treatment

In two recent clinical trials of Harvoni and Sovaldi in the treatment of young people between the ages of 12 and 17, the drugs eliminated all traces of the hepatitis C virus in 97 to 100 percent of patients, generally in 12 weeks.

Many insurers have required that adults with hepatitis C be very sick before they can get access to expensive drug treatment. But Medicaid has special rules that may get kids and teens access sooner.

(Image credit: Lloyd Fox/Baltimore Sun/TNS via Getty Images)